The Treatment Modalities in Sacral Chordomas

Sakral kordomalar nispeten nadir görülen, lokal invaziv, malign tümörlerdir. Yüksek başarısızlık oranı ve kötü fonksiyonel geri dönüşle karakterizedirler. Kliniğimizde 2000-2006 yılları arasında takip edilen altı sakral kordoma olgusu sunulmuştur. Primer malign bir kemik tümörü olan sakrokoksigeal kordomaların radyoterapi ve kemoterapiye yetersiz yanıtı nedeniyle optimal tedavi olarak komplet eksizyon gereklidir. Kordomaların komplet çıkarılması için uygun cerrahi sınır, tutulan dokulara ve tümörün lokalızasyonuna göre değişmektedir. Tümörün derin dokulara invazyonu sonucu peivik instabilite ve üriner-fekal inkontinans gibi komplikasyonlardan korunmak amacıyla lokal rekürrens ile sonuçlanan inkomplet eksizyon yapılmaktaysa da, biz tedavide komplet rezeksiyon ve lokal rekürrens halinde ise agresif müdahaleyi savunuyoruz.
Anahtar Kelimeler:

Kordoma, sakrokoksigeal.

Sakral Kordomalarda Tedavi Yaklaşımları

Sacral chordomas are relatively rare, locally invasive, maiignant neoplasms. Chordomas is characterized by a high failure rate and a poor fonctional outcome. Six patients were treated for sacral chordoma between 2000-2006 in our clinic. Due to inadequate response to chemo and radiotheraphy, sacrococcygeal chordoma which is a primary malign bone tumour should be excised completely as an optimal therapeutic modality. Complete surgical exploration depends on site of affected tissues and tumour localisation. To prevent these postoperative complications such as pelvic instability, urinary-feacal incontinence, incomplet excision may be a treatment option vvith high local reccurence rate. We advocate an attempt at complete resection and aggressive treatment of local reccurence.

___

  • Özdemir M. Sacrococsygeal chordoma: A case report. İzmir Atatürk Eğitim Hastanesi Tıp Dergisi 2005:43.
  • Fuchs B, Dickey I, Yaszemski M, inwards C, Sim F. Operative management of sacral chordoma. The Journal of Bone&Joint Surgery 2005;87-A:2211-6.
  • Baratti D, Gronchi A, Pennacchioli E, et al. Chordoma: Natural history and results in 28 patients treated at a single institution. Ann Surg Oncol 2003;10:291-6.
  • Şar C. Total sacrectomy and lumbopelvic reconstruction for primary tumors of the sacrum. Açta Orthop Traumatol Turc 2001;35:79-83.
  • Yonemoto T, Tatezaki S, Takenouchi T, Ishii T, Satoh T, Moriya H. The surgical management o f sacrococcygeai chordoma. Cancer 1999;85:878-83.
  • Darly R, Fourney MD, Gokasian Z. Current management of sacral chordoma. Neurosurg Focus 2003; 15.
  • Anson KM, Byrne PO, Robertson İD, et al. Radical excision of sacrococcygeai tumours. Br J Surg 1994;81:460-1.
  • Smith J, Ludwig RL, Marcove RC. Sacrococcygeai chordo­ ma. A clinicoradiological study of 60 patients. Skeletal Radiol 1987;16:37-44.
  • Greenspan A. Tumors and Tumor-Like Lesions. Part 4. 3rd ed. Philadelphia: Lippincott VVİlliams&VVUkins, 2000:701-3.
  • Stephens GC, Schwartz HS. Lumbosacral chordoma resec- tion: Image integration and surgical planning. J Surg Oncol 1993;54:226-32.
  • Dahlin DC, McCarty LS. Chordoma: A study of 59 cases. Cancer 1952;5:1170-8.
  • Gökasian ZL, Romsdahl MM, Kroll SS, et al. Total sacrecto­ my and Galveston L-rod reconstruction for malignant neo- plasms. Technical note. J Neurosurg 1997;87:781-7.
  • Tomita K, Tsuchiya H. Total sacrectomy and reconstruction forhuge sacral tumors. Spine 1990;15:1223-7.
  • Gunterberg B, Kewenter J, Petersen I, Stener B. Anorectal function after majör resections of the sacrum with bilateral or unilateral sacrifice of sacral nerves. Br J Surg 1976;63:546-54.
  • Gunterberg B, Romanus B, Stener B. Pelvic strength after majör amputation of the sacrum. An experimental study. Açta Orthop Scand 1976;47:635-42.
  • Ishii K, Chiba K, Watanabe M, Yabe H, Fujimura Y, Toy ama Y. Local reccurence after S2-3 sacrectomy in sacral chor­ doma. Report of four cases. J Neurosurg 2002;97:98-101.
Acta Oncologica Turcica-Cover
  • ISSN: 0304-596X
  • Başlangıç: 2015
  • Yayıncı: Dr. Abdurrahman Yurtaslan Ankara Onkoloji EAH
Sayıdaki Diğer Makaleler

Metachronous Thymoma and Nonsmall Celi Lung Cancer A Case Report

Yeşim ELGİN, Aytül ÖZGEN, Bülent KÜÇÜKPLAKÇI, Ergun SANRI, Cem MISIRLIOĞLU, Taciser DEMİRKASIMOĞLU, V. Işıl UĞUR, Ş. Pınar KARA, Nadi ÖZDAMAR

A Case Report of Preadolesarıt Tyroglossal Cyst Papillary Carcinoma Established By Tyroglossal Cyst Excision

Oğuz TARCAN, Haluk ULUCANLAR, Aybala AĞAÇ, Suat KUTUN, Necmi YÜCEKULE, Abdullah ÇETİN

Mature Teratoma of the Uterine Cervix

Jale METİNDİR, Zeynep KAHYAOĞLU, Süleyman DEMİR

Is Minimum 10 Nodes Removed to Correctly Determine The Breast Cancer Patients Who Had Negative Axillary Status Sufficient?

Kaptan GÜLBEN, Mustafa YİĞİT, Uğur BERBEROĞLU

Management of Menopausal Symptoms in Patients Breast Cancer

Jale METİNDİR

The Comparison Betvveen 21 G and 22 G Injector Needles in the Fine-Needle Aspiration Biopsy of Thyroid Nodules

Bilgin Kadri ARIBAŞ, Dilek Nil ÜNLÜ, Gürbüz DİNGİL, Sevim ÖZDEMİR, Pelin DEMİR, Zekiye Pekol ŞİMŞEK, Ümit ÜNGÜL, Aliye Ceylan ZARALI

Fetal Ouadrigeminal Arachnoid Cyst Secondary to Usage of Valproic Acid

Gülşah Bayram KABAÇAM, Z. Nilgün Yildirim ÖZBAY, Bige SAYIN, Perihan SOYDİNÇ, Doğan DEDE

The Value of A Second Transurethral Resection in Patients with Superficial Bladder Cancer

Fatih HIZLI, Yurdaer KAYNAK, Emine BENZER, Ferhat BERKMEN

Seroprevalerıce of Anti-HDV Antibody in HBsAg Positive Patients

Gülşen İSKENDER, M. Cihat OĞAN, Kamuran SAYILIR, Ece BİLEN DİRİM, Sema BATI, Müfide ÇİMENTEPE, Ayla YENİGÜN

The Efficacy of US-Guided Fine-Needle Aspiration Biopsy in Adrenal Masses

Bilgin Kadri ARIBAŞ, Gürbüz DİNGİL, Ümit ÜNGÜL